Q1 2024 · 13F-HR
BRAIDWELL LPholdings as filed
Filed 2024-05-15 · accession 0001920938-24-000004
$3.10B
Reported value
70
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 40131MAB5 | GH 0 11/15/27 | GUARDANT HEALTH INC | $183.6M | 5.92% | 268,252,000 | Common | SOLE |
| 10806XAB8 | BBIO 2.5 03/15/27 | BRIDGEBIO PHARMA INC | $146.2M | 4.71% | 135,838,000 | Common | SOLE |
| 30063PAC9 | EXAS 0.375 03/01/28 | EXACT SCIENCES CORP | $133.1M | 4.29% | 144,000,000 | Common | SOLE |
| 67011XAB9 | NVCR 0 11/01/25 | NOVOCURE LTD | $124.6M | 4.02% | 135,834,000 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $122.4M | 3.95% | 1,842,515 | Common | SOLE |
| 670704AJ4 | GMED 0.375 03/15/25 | NUVASIVE INC | $109.0M | 3.51% | 114,206,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $100.7M | 3.25% | 730,209 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $86.5M | 2.79% | 219,824 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $82.8M | 2.67% | 1,212,703 | Common | SOLE |
| 64049MAB6 | NEO 0.25 01/15/28 | NEOGENOMICS INC | $82.6M | 2.66% | 103,580,000 | Common | SOLE |
| 252131AK3 | DXCM 0.25 11/15/25 | DEXCOM INC | $71.6M | 2.31% | 65,000,000 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $69.8M | 2.25% | 1,243,795 | Common | SOLE |
| 457669AA7 | — | INSMED INC | $69.4M | 2.24% | 64,887,000 | Common | SOLE |
| 45784PAK7 | PODD 0.375 09/01/26 | INSULET CORP | $68.9M | 2.22% | 66,000,000 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $66.0M | 2.13% | 295,892 | Common | SOLE |
| 56600D107 | MRVI | MARAVAI LIFESCIENCES HLDGS I | $62.6M | 2.02% | 7,221,960 | Common | SOLE |
| 803607AD2 | SRPT 1.25 09/15/27 | SAREPTA THERAPEUTICS INC | $59.3M | 1.91% | 50,666,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $58.5M | 1.88% | 713,100 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $56.3M | 1.81% | 1,308,011 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $56.1M | 1.81% | 483,257 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $55.5M | 1.79% | 169,252 | Common | SOLE |
| 10806XAD4 | BBIO 2.25 02/01/29 | BRIDGEBIO PHARMA INC | $55.1M | 1.78% | 67,294,000 | Common | SOLE |
| 46333XAH1 | IRWD 1.5 06/15/26 | IRONWOOD PHARMACEUTICALS INC | $53.7M | 1.73% | 52,740,000 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $51.1M | 1.65% | 2,476,804 | Common | SOLE |
| 761299AB2 | TVTX 2.5 09/15/25 | TRAVERE THERAPEUTICS INC | $49.6M | 1.60% | 56,031,000 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $49.6M | 1.60% | 1,130,235 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $48.8M | 1.57% | 737,379 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $45.4M | 1.46% | 614,531 | Common | SOLE |
| 05337M104 | — | AVADEL PHARMACEUTICALS PLC | $45.1M | 1.45% | 2,668,549 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $42.5M | 1.37% | 450,676 | Common | SOLE |
| 69913P105 | FNAUSD | PARAGON 28 INC | $41.6M | 1.34% | 3,365,609 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $40.1M | 1.29% | 100,500 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $35.9M | 1.16% | 2,173,704 | Common | SOLE |
| 48576UAA4 | — | KARYOPHARM THERAPEUTICS INC | $35.8M | 1.15% | 65,976,000 | Common | SOLE |
| 02081GAB8 | ATEC 0.75 08/01/26 | ALPHATEC HLDGS INC | $33.9M | 1.09% | 32,434,000 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $33.5M | 1.08% | 1,052,485 | Common | SOLE |
| 68752L100 | KIDS | ORTHOPEDIATRICS CORP | $32.3M | 1.04% | 1,107,770 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $31.5M | 1.02% | 177,089 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $31.1M | 1.00% | 3,743,999 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $30.4M | 0.98% | 3,489,843 | Common | SOLE |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $27.5M | 0.89% | 1,392,716 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $27.4M | 0.88% | 47,149 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $26.3M | 0.85% | 142,836 | Common | SOLE |
| 64157F103 | NVROEUR | NEVRO CORP | $25.7M | 0.83% | 1,776,368 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $21.8M | 0.70% | 101,492 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $21.1M | 0.68% | 1,240,865 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $20.8M | 0.67% | 906,820 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $20.7M | 0.67% | 1,322,277 | Common | SOLE |
| 46333XAF5 | — | IRONWOOD PHARMACEUTICALS INC | $19.9M | 0.64% | 20,000,000 | Common | SOLE |
| 405024AB6 | HAE 0 03/01/26 | HAEMONETICS CORP MASS | $19.8M | 0.64% | 21,500,000 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $19.5M | 0.63% | 515,000 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $19.1M | 0.62% | 218,896 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $18.7M | 0.60% | 435,823 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $17.2M | 0.55% | 3,379,577 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $15.9M | 0.51% | 1,162,374 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $14.8M | 0.48% | 1,147,154 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $14.3M | 0.46% | 2,380,704 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $12.9M | 0.42% | 1,300,000 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $12.2M | 0.39% | 2,377,647 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $10.7M | 0.34% | 344,827 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $9.8M | 0.32% | 660,022 | Common | SOLE |
| 24344T101 | DCPHEUR | DECIPHERA PHARMACEUTICALS IN | $9.6M | 0.31% | 609,643 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $8.0M | 0.26% | 704,344 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $7.0M | 0.22% | 752,541 | Common | SOLE |
| 232109AG3 | — | CUTERA INC | $6.4M | 0.21% | 29,000,000 | Common | SOLE |
| 23306J101 | — | DBV TECHNOLOGIES S A | $5.9M | 0.19% | 7,843,285 | Common | SOLE |
| 232109AD0 | — | CUTERA INC | $5.7M | 0.19% | 25,240,000 | Common | SOLE |
| 690145107 | OMGBP | OUTSET MED INC | $5.3M | 0.17% | 2,400,427 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $4.4M | 0.14% | 1,357,490 | Common | SOLE |
| 415858109 | HROW | HARROW INC | $1.7M | 0.05% | 125,967 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.